Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/514
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNayiager, Sauithreeen
dc.contributor.authorKivitz, Alan Jen
dc.contributor.authorOelke, Kurten
dc.contributor.authorDelaet, Ingriden
dc.contributor.authorLudivico, Charlesen
dc.contributor.authorElegbe, Ayanbolaen
dc.contributor.authorNash, Peteren
dc.contributor.authorGenovese, Mark Cen
dc.contributor.authorPalmer, Williamen
dc.contributor.authorRodriguez, Cristianen
dc.date.accessioned2018-06-16T20:35:04Z-
dc.date.available2018-06-16T20:35:04Z-
dc.date.issued2013en
dc.identifier.citation65, (5), 2013, p. 718-728en
dc.identifier.otherRISen
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/514-
dc.languageenen
dc.relation.ispartofArthritis care & researchen
dc.titleImmunogenicity, Safety, and Efficacy of Abatacept Administered Subcutaneously With or Without Background Methotrexate in Patients With Rheumatoid Arthritis: Results From a Phase III, International, Multicenter, Parallel‐Arm, Open‐Label Studyen
dc.typeArticleen
dc.identifier.risid557en
dc.description.pages718-728en
item.grantfulltextnone-
item.openairetypeArticle-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
Appears in Sites:Sunshine Coast HHS Publications
Show simple item record

Page view(s)

54
checked on Apr 24, 2025

Google ScholarTM

Check


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.